“The Importance of Procalcitonin for Antimicrobial Stewardship in Patients With Lower Respiratory Tract Infections in the Emergency Department”
bioMérieux* presents…“The Importance of Procalcitonin for Antimicrobial Stewardship in Patients With Lower Respiratory Tract Infections in the Emergency Department”
This webinar will explore how using a procalcitonin (PCT) driven protocol in the Emergency Department can aid clinicians in decisions about hospital admission versus treatment in the home setting. Session will look at the existing data on procalcitonin in patients with presumed Lower Respiratory Tract Infections (LRTI) and how antibiotic stewardship teams could use this biomarker in shaping their clinical decisions. Lastly, presenter will examine what stewardship metrics may be impacted by using a procalcitonin-guided protocol.
- Understand the role of procalcitonin (PCT) for acute presentation in the emergency department of lower respiratory tract infection and sepsis
- Understand appropriate use of procalcitonin (PCT) and how to interpret pct levels in the emergency department
John Boreyko, PharmD, BCIDP | Co-Director of the Antimicrobial Stewardship Program | Clinical Infectious Diseases Pharmacist | Duke Regional Hospital
Questions should be directed to bioMérieux: (800) 682 2666
* NOTE: This is a HealthTrust contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.